Bausch Health Companies Inc (NYSE:BHC) shares traded 1.20% higher at $5.88 on Wall Street last session.
BHC stock price is now -13.40% away from the 50-day moving average and -24.63% away from the 200-day moving average. The market capitalization of the company currently stands at $2.16B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $8, Raymond James recently initiated with Mkt Perform rating for Bausch Health Companies Inc (NYSE: BHC). On September 20, 2023, Jefferies Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock increasing its target price from $9 to quote $16, while ‘TD Cowen’ rates the stock as ‘Market Perform’
In other news, Carson Seana, EVP, General Counsel sold 6,313 shares of the company’s stock on Mar 04 ’24. The stock was sold for $61,867 at an average price of $9.80. Upon completion of the transaction, the EVP, General Counsel now directly owns 499,905 shares in the company, valued at $2.94 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 05 ’23, EVP, General Counsel Carson Seana sold 220 shares of the business’s stock. A total of $1,624 was realized by selling the stock at an average price of $7.38. This leaves the insider owning 382,925 shares of the company worth $2.25 million. A total of 2.57% of the company’s stock is owned by insiders.
During the past 12 months, Bausch Health Companies Inc has had a low of $3.96 and a high of $11.46. The fifty day moving average price for BHC is $6.7648 and a two-hundred day moving average price translates $7.7906 for the stock.
The latest earnings results from Bausch Health Companies Inc (NYSE: BHC) was released for 2024-03-31. The company reported revenue of $2.15 billion for the quarter, compared to $1.94 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 10.75 percent.